BioPorto A/S (CPH:BIOPOR)
Denmark
· Delayed Price · Currency is DKK 0.994
-0.066 (-6.23%)
Apr 28, 2026, 4:59 PM CET
BioPorto Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 40.29 | 36.24 | 30.96 | 28.97 | 24.25 | Upgrade
|
| Revenue Growth (YoY) | 11.16% | 17.07% | 6.87% | 19.44% | 4.52% | Upgrade
|
| Cost of Revenue | 9.9 | 11.71 | 10.78 | 9.93 | 9.21 | Upgrade
|
| Gross Profit | 30.39 | 24.53 | 20.18 | 19.04 | 15.04 | Upgrade
|
| Selling, General & Admin | 58.32 | 63.05 | 54.9 | 63.05 | 50.04 | Upgrade
|
| Research & Development | 50.47 | 33.53 | 25.45 | 34.94 | 30.26 | Upgrade
|
| Operating Expenses | 108.79 | 96.58 | 80.35 | 97.99 | 80.3 | Upgrade
|
| Operating Income | -78.39 | -72.05 | -60.16 | -78.94 | -65.26 | Upgrade
|
| Interest Expense | -0.57 | -0.45 | -0.57 | -1.09 | -0.91 | Upgrade
|
| Interest & Investment Income | 0.51 | 1.64 | 1.04 | 0.04 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.28 | 0.9 | -0.43 | 1.14 | 2.46 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.21 | -0.38 | -0.07 | -0.12 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -79.94 | -70.34 | -60.2 | -78.96 | -63.84 | Upgrade
|
| Asset Writedown | - | - | -1.01 | -2.58 | - | Upgrade
|
| Other Unusual Items | -7.7 | -3.4 | - | - | - | Upgrade
|
| Pretax Income | -87.64 | -73.74 | -61.21 | -81.55 | -63.84 | Upgrade
|
| Income Tax Expense | -5.52 | -5.5 | -4.88 | -5.62 | -6.73 | Upgrade
|
| Net Income | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 | Upgrade
|
| Net Income to Common | -82.12 | -68.24 | -56.33 | -75.92 | -57.11 | Upgrade
|
| Shares Outstanding (Basic) | 538 | 406 | 358 | 319 | 267 | Upgrade
|
| Shares Outstanding (Diluted) | 538 | 406 | 358 | 319 | 267 | Upgrade
|
| Shares Change (YoY) | 32.47% | 13.18% | 12.54% | 19.11% | 30.21% | Upgrade
|
| EPS (Basic) | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 | Upgrade
|
| EPS (Diluted) | -0.15 | -0.17 | -0.16 | -0.24 | -0.21 | Upgrade
|
| Free Cash Flow | -77.07 | -83.93 | -55.5 | -52.89 | -64.71 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -0.21 | -0.15 | -0.17 | -0.24 | Upgrade
|
| Gross Margin | 75.44% | 67.68% | 65.19% | 65.73% | 62.01% | Upgrade
|
| Operating Margin | -194.59% | -198.80% | -194.34% | -272.51% | -269.05% | Upgrade
|
| Profit Margin | -203.83% | -188.29% | -181.95% | -262.08% | -235.48% | Upgrade
|
| Free Cash Flow Margin | -191.29% | -231.58% | -179.26% | -182.58% | -266.79% | Upgrade
|
| EBITDA | -77.64 | -71.36 | -59.16 | -77.81 | -64.2 | Upgrade
|
| EBITDA Margin | -192.72% | -196.90% | -191.09% | -268.60% | -264.70% | Upgrade
|
| D&A For EBITDA | 0.75 | 0.69 | 1.01 | 1.13 | 1.05 | Upgrade
|
| EBIT | -78.39 | -72.05 | -60.16 | -78.94 | -65.26 | Upgrade
|
| EBIT Margin | -194.59% | -198.80% | -194.34% | -272.51% | -269.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.